Effects of lipoic acid in an experimentally induced hypertensive and diabetic rat model

Clinical and Experimental Hypertension

Volumn 35, Issue 5, 2013, Pages 373-381

  Micili, Serap Cilaker ^a   Ergur, Bekir Uǧur ^a   Ozoǧul, Candan ^b   Sarioǧlu, Sülen ^a   Baǧriyanik, H Alper ^a   Tuǧyan, Kazim ^a   Pekcetin, Cetin ^a   Sonmez, Ulker ^a   Tekmen, Isil ^a   Erbil, Guven ^a   Akdoǧan, Gul Guner ^a   Ozyurt, Doǧan ^a   Buldan, Zisan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Diabetes mellitus; Histology; Kidney; Nephrectomy; Ultrastructure

Indexed keywords

CREATININE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFECT; GLOMERULOSCLEROSIS; GLOMERULUS; HYPERTENSION; KIDNEY INJURY; MALE; MICROSCOPY; MORPHOMETRICS; NEPHRECTOMY; NONHUMAN; SYSTOLIC BLOOD PRESSURE;

EID: 84885006693     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.732647     Document Type: Article

References (34)

1. Nolan CR, Schrier RW. Kidney in hypertension. In: Schrier RW, ed. Renal and Electrolyte Disorders, 6th ed. Lippincott: Williams & Wilkins; 2005:272-324.
2. Oldfield MD, Cooper ME. The biochemistry and pathophysiology of renal lesions in type 2 diabetes. In: Mogensen CE, ed. Diabetic Nephropathy in Type 2 Diyabetes, 1st ed. London: Science Press; 2002:41-56.
3. Williams B, ed. Epidemiology and pathogenesis of hypertension in people with diabetes mellitus. In: Hypertension in Diabetes, 1st ed. London, New York: Martin Dunitz; 2003:3-24.
4. Maritim AC, Sanders RA, Watkins JB. Effects of lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 2003; 14:288-294.
5. Altan N, Dinçel AS, Koca C. Diabetes Mellitus ve Oksidatif Stres. Turk J Biochem 2006; 31(2):51-56.
6. Özkan Y, Yilmaz Ö, Öztürk A, Eŗsan Y. Effects of triple antioxidant combination (vitamin E, vitamin C and α-lipoic acid) with insulin on lipid and cholesterol levels and fatty acid composition of brain tissue in experimental diabetic and non-diabetic rats. Cell Biol Intern 2005; 29:754-760.
7. Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney: effect of DL-α-lipoic acid. Free Radical Biol Med 2003; 34:186-195.
8. Tylicki L, Rutkowski B, Hörl WH. Antioxidants: a possible role in kidney protection. Kidney Blood Press Res 2003; 26:303-314.
9. Cohuet G, Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Therapeut 2006; 111:81-98.
10. Guneli E, Tugyan K, Ozturk H, Gumustekin M, Cilaker S, Uysal. N. Effect of melatonin on testicular damage in streptozotocininduced diabetes rats. Eur Surg Res 2008; 26:354-360.
11. Guray M, Sarioglu S, Turkmen M, et al. Cyclosporine a toxicity in association with reduced renal mass. Transplant Proc 2003; 35:3128-3133.
12. Cakatay U, Kayali R, Kiziler AR, Aydemir B. Postmitotic tissue selenium and manganese levels in alpha-lipoic acidsupplemented aged rats. Chem Biol Interact 2008; 171: 306-311.
13. Bal E, Murat N, Demir Ö, et al. Restraint stress impairs erectile responses in rats. Tohoku J Exp Med 2009; 217:239-242.
14. Newbold KM, Howie AJ, Girling AJ, Kizaki T, Bryan RL, Carey MP. Asimple method for assessment of glomerular size and its use in the study of kidneys in acromegaly and compensatory renal enlargement. J Pathol 1989; 158(2):139-146.
15. Howie AJ, Ferreira MAS, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001; 16:1163-1169.
16. Newbold KM, Howie AJ, Koram A, Adu D, Michael J. Assessment of glomerular size in renal biopsies including minimal change nephropathy and single kidneys. J Pathol 1990; 160(3):255-258.
17. Nithiyananthan R, Dodson PM. Non-pharmacological strategies for blood pressure control in diabetic subjects. In: Williams B, ed. Hypertension in Diabetes, 1st ed. London, Newyork: Martin Dunitz; 2003:267-284.
18. Souza MS, Machado UF, Okamoto M, et al. Reduced cortical renal GLUT1 expression induced by angiotensin-converting enzyme inhibition in diabetic spontaneously hypertensive rats. Braz J Med Biol Res 2008; 41(11):960-968.
19. Hajsadeghi S, Fereshtehnejad SM, Pourshirmohammadi- Sabzevari M, Khamseh ME, Noohi F. Renal artery stenosis in hypertensive patients with or without type 2 diyabetes: a comparative magnetic resonance angiography study. Arch Iranian Med 2009; 12(3):250-255.
20. Bleyer AJ, Appel RG. Risk factor associated with hypertensive nephrosclerosis. Nephron 1999; 82:193-198.
21. Jenette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia: Lippincott- Raven, 1998; 2:943-1002.
22. MelhemMF, Craven PA, Liachenko J,Derubertis FR. α-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diyabetes. J Am Soc Nephrol 2002; 13:108-116.
23. Cohuet G, Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Therapeut 2006; 111:81-98.
24. Vasdev S, Gill V, Parai S, Gadag V. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem 2005; 275:135-141.
25. Midaoui AE, de Champlain J. Prevention of hypertension, insülin resistance and oxidative stress by α-lipoic acid. Hypertension 2002; 39:303-307.
26. Cao Z, Bonnet F, Candido R, et al. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 2002; 13:1773-1787.
27. Eguíluz Lumbreras P, Hernández AP, Gómez Zancajo VR, et al. Nephrectomy in polycystic kidney disease before transplantation. Archivos Espanoles De Urologia 2010; 63:403-9.
28. Kang DH, Joly AH, Oh SE, et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12:1434-1447.
29. Hattori T, Shindo S, Kawamura H. Apoptosis and expression of Bax protein and Fas antigen in glomeruli of a remnant-kidney model. Nephron 1998; 79(2):186-191.
30. Bhatti F, Mankhey RW, Asico L, et al. Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int 2005; 67:1371-1380.
31. Thomas GL, Yang B, Wagner BE, Savill J, El Nahas AM. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 1998; 13(9):2216-2226.
32. Benigni A, Perico N, Gaspari F, Zoja C. Increased renal endothelin production in rats with reduced renal mass.AmJ Physiol 1991; 29:331-339.
33. Shore I,Moss J. Electronmicroscopy in diagnostic renal pathology. Current Diagnostic Pathol 2002; 8:207-215.
34. Aunapuu M, Pechter Ü, Arend A, et al. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment. Medicina 2003; 39:975-979.